Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma

Published:2009-06-22 Issue:32 Volume:28 Page:2903-2909
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Akita H,Zheng Z,Takeda Y,Kim C,Kittaka N,Kobayashi S,Marubashi S,Takemasa I,Nagano H,Dono K,Nakamori S,Monden M,Mori M,Doki Y,Bepler G

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2009158.pdf

Reference48 articles.

1. Bachem MG, Schunemann M, Ramadani M, Siech M, Beger H, Buck A et al. (2005). Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128: 907–921.

2. Bepler G, Kusmartseva I, Sharma S, Gautam A, Cantor A, Sharma A et al. (2006). RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer. J Clin Oncol 24: 4731–4737.

3. Bepler G, Sharma S, Cantor A, Gautam A, Haura E, Simon G et al. (2004). RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer. J Clin Oncol 22: 1878–1885.

4. Bergman AM, Eijk PP, Ruiz van Haperen VW, Smid K, Veerman G, Hubeek I et al. (2005). in vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant. Cancer Res 65: 9510–9516.

5. Boeck S, Heinemann V . (2008). Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer. J Clin Oncol 26: 1178–1179; author reply 1179.

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the mode of action of cisplatin combined with a phosphoramidate modification of gemcitabine;2024-05-14

2. Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness;Drug Resistance Updates;2024-03

3. Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer;British Journal of Pharmacology;2024-01-22

4. Defining the Mode of Action of Cisplatin Combined with a Phosphoramidate Modification of Gemcitabine;2024

5. Prognostic value of RRM1 and its effect on chemoresistance in pancreatic cancer;Cancer Chemotherapy and Pharmacology;2023-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3